Millipore Corporation Introduces New Tools for Vascular Biology Research

Billerica, Mass. – March 25, 2009 - Millipore Corporation (NYSE: MIL) today announced the release of EndoGRO™ products for vascular research, including human umbilical vein endothelial cells (HUVEC) and advanced media formulations for endothelial cell culture. Endothelial cells play a key role in a range of biological processes. In vitro cell models are commonly used for physiological and pharmacological investigations of angiogenesis, clotting, and inflammation, as well as arteriosclerosis and vascular disorders. EndoGRO advanced media products include four uniquely optimized formulations for large vessel and microvascular endothelial cells, as well as low-passage HUVEC.

EndoGRO media formulations have lower serum concentrations than standard endothelial cell culture media, yet have been shown to support endothelial cell growth rates that exceed other commercially available serum-containing media, while maintaining excellent cell morphology. In addition, the media have no phenol red or antimicrobials, which can cause cell stress and mask natural biological processes.

EndoGRO human umbilical vein endothelial cells are cultured for only one passage before cryopreservation to ensure the highest viability and culture life. Growth of these cells is enhanced by the use of EndoGRO media. EndoGRO cells and media are part of Millipore’s expanding selection of specialty cell culture tools. More information is available at www.millipore.com/cellbiology.